Letter to the Editor.
Cannabis-like drugs known as “semi-synthetic cannabinoids” (SSCs) and other substitutes continue to be sold commercially throughout Ireland despite recent law changes that attempted to prohibit their sale. The continued provision of these substances is suggestive of flaws in Irish drug policy and enforcement that require ongoing attention. To situate the reader and highlight the urgency of the present situation, this Letter outlines the following: (1) the origins of SSCs; (2) the health risks of SSCs; (3) the need for further political and legislative action; and (4) the future of Irish drug policy.